SCHEMBL4374433

SCHEMBL4374433

CC(=O)OCC(=O)OON(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.33
FAAH O00519 1/20 0.32
CHRM5 P08912 2/20 0.31
CHRM1 P11229 2/20 0.31
CHRM3 P20309 2/20 0.31
PGR P06401 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRNB2 P17787 1/20 0.31
TBXA2R P21731 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA7 P36544 1/20 0.31
CHRNA4 P43681 1/20 0.31
CHRNA10 Q9GZZ6 1/20 0.31
CHRNA9 Q9UGM1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7365892 0.81 ALDH1A1 (0.48) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL675824 0.75 ALDH1A1 (0.42) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL118942 0.71 ALDH1A1 (0.48) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL2397840 0.69 ALDH1A1 (0.47) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL2607864 0.69
SCHEMBL13756256 0.68 ALDH1A1 (0.50) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL8742043 0.67 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL1006090 0.67 ALDH1A1 (0.65) ALDH1A1HSD17B10LMNASMN1; SMN2TSHR
SCHEMBL10621262 0.67 ALDH1A1 (0.50) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH
SCHEMBL22558178 0.67 ALDH1A1 (0.45) ALDH1A1HSD17B10LMNASMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117540-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-24 WO disclosed